Navigation Links
Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod)

gen to prevent clot formation and reduces blood viscosity, which may lead to improved blood flow within the affected area. Ancrod also indirectly causes the clot to break up. In contrast, other approved drugs or drugs in clinical development for AIS do not directly target fibrinogen. Ancrod has multiple mechanisms of action to help rapidly achieve three biological effects: blood viscosity reduction, thrombus modification, and alteration of hemostasis. The three effects of ancrod provide a potent yet potentially safe means of limiting brain damage with stroke.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. (NTI) is a biotechnology company engaged in the business of acquiring and developing central nervous system related drug candidates. The Company is focused on therapies for neurological conditions that occur in connection with ischemic stroke, brain cancer, Alzheimer's disease and dementia. The Company's strategy is to in- license and develop later-stage drug candidates that target major medical needs and that can be rapidly commercialized. NTI's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy. For further information, please visit NTI's website at http://www.ntii.com.

A full press kit is available at the NTI booth (#171) or by emailing: Kamala@corinthgroup.com

NOTE: Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including: our need for additional capital, risks related to clinical trials and the regulatory approval and successful commercialization of our products, the inherent risk of failure in developing product candidates based on new technologies, the risks associated with the cost of clinical developme
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Inspire Announces Presentations at Two European Scientific Conferences
6. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
9. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
10. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
11. Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting
Post Your Comments:
(Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
(Date:9/1/2015)... September 1, 2015 Diabetes, ... 2015 market research report that charts the changing ... the added health concerns resulting from the metabolic ... factors: cardiovascular disease (CVD). Complete report ... spread across 270 pages, profiling 66 companies and ...
(Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 2Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 3Diabetes, Metabolic Syndrome and Cardiovascular Disease Market 2015 Research Report 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Md., April 26, 2012 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... providing health care services in China through the operations ... care hospitals and affiliated ambulatory clinics, today announced that ... first quarter of 2012 ended March 31, 2012 on ...
... 2012 Medical sales recruitment specialists Advance ... new global medical device survey for 2012-2013 suggesting a ... climate. The report, which was published this ... a highly detailed analysis drawn from ICD research,s panel ...
Cached Medicine Technology:Chindex International, Inc. to Report First Quarter 2012 Financial Results 2Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry 2
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... ... center management, recently opened registration for the company’s second Introduction to Hyperbaric Medicine ... held October 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. ...
(Date:8/31/2015)... Michigan (PRWEB) , ... August 31, 2015 , ... ... a new weight management program that is unique to the Lake Orion area. ... Oakland and Macomb County. , WEmovestrong’s weight management program will incorporate group ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence ... , Starting September 1st they are offering pre and postnatal fitness classes ... Body, Healthy Baby." , More information can be found at 248-601-6683. , Women’s ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Patients who ... and those who are interested in learning more about the procedure beyond the information ... , Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand to ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Bay Pines ... Veterans residing across southwest Florida by hiring more doctors and nurses and expanding existing ... expanded services. , In early July, Dr. Anthony Jabre was selected to lead and ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3
... − Health prevention strategies to help Canadians achieve their ... of healthy years to the average lifespan and save ... reduced cardiovascular disease, says noted cardiologist Dr. Clyde Yancy. ... and Stroke Foundation of Canada Lecture at the opening ...
... to mutation in one of two tumor suppressor genes, TSC1 ... body and skin. These tumors can be unsightly and cause ... may cause seizures and in the kidney, liver or heart, ... the organ to fail. New research published in BioMed Central,s ...
... Violent deaths are outpacing traditional causes of maternal mortality, ... partner are often a factor, researchers report. ... suicide were more common than what we think of ... L. Palladino, an obstetrician-gynecologist and educational researcher at Georgia ...
... Researchers at the University of Houston (UH) are recommending ... sclerosis, Alzheimer,s and cardiovascular diseases. In an invited ... Drug Discovery, scientists at the Center for Nuclear Receptors ... years of research following the team,s 1996 discovery of the ...
... up, irritability and unexplained crying in infants are ... acid-suppressing drugs for these symptoms. However, gastroesophageal reflux ... symptoms in otherwise thriving infants, and in his ... Eric Hassall cautions against over-diagnosis of GERD and ...
... as a result of the restrictions on the number ... shift changes, and resulting consecutive sign-outs, during patient handovers ... and quality of information conveyed between residents, according to ... University of Virginia Healthsystem in the US and his ...
Cached Medicine News:Health News:Simple lifestyle changes can add a decade or more healthy years to the average lifespan 2Health News:Simple lifestyle changes can add a decade or more healthy years to the average lifespan 3Health News:Simple lifestyle changes can add a decade or more healthy years to the average lifespan 4Health News:Feed a cold -- starve a tumor 2Health News:Homicide, suicide outpace traditional causes of death in pregnant, postpartum women 2Health News:Homicide, suicide outpace traditional causes of death in pregnant, postpartum women 3Health News:New drug strategies for Alzheimer's, multiple sclerosis examined at UH 2Health News:Acid-suppressing medications may be overprescribed for infants 2Health News:Acid-suppressing medications may be overprescribed for infants 3Health News:Hospital patients suffer in shift shuffle 2
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... to prevent a microplate from sticking to the block ... level of sealing performance, which means you can use ...
... Designed for use with the Moto Alpha unit, these ... cycle sequencing, in which several successive runs may be ... Alpha unit is engineered to prevent a microplate from ... pads provide an improved level of sealing performance, which ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: